These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 15357984)
1. Syntheses and anti-MRSA activities of the C3 analogs of mansonone F, a potent anti-bacterial sesquiterpenoid: insights into its structural requirements for anti-MRSA activity. Shin DY; Kim SN; Chae JH; Hyun SS; Seo SY; Lee YS; Lee KO; Kim SH; Lee YS; Jeong JM; Choi NS; Suh YG Bioorg Med Chem Lett; 2004 Sep; 14(17):4519-23. PubMed ID: 15357984 [TBL] [Abstract][Full Text] [Related]
2. The structure-activity relationships of mansonone F, a potent anti-MRSA sesquiterpenoid quinone: SAR studies on the C6 and C9 analogs. Suh YG; Kim SN; Shin DY; Hyun SS; Lee DS; Min KH; Han SM; Li F; Choi EC; Choi SH Bioorg Med Chem Lett; 2006 Jan; 16(1):142-5. PubMed ID: 16236511 [TBL] [Abstract][Full Text] [Related]
3. CP5484, a novel quaternary carbapenem with potent anti-MRSA activity and reduced toxicity. Maruyama T; Yamamoto Y; Kano Y; Kurazono M; Matsuhisa E; Takata H; Takata T; Atsumi K; Iwamatsu K; Shitara E Bioorg Med Chem; 2007 Oct; 15(19):6379-87. PubMed ID: 17681767 [TBL] [Abstract][Full Text] [Related]
4. A new class of anti-MRSA and anti-VRE agents: preparation and antibacterial activities of indole-containing compounds. Yamamoto Y; Kurazono M Bioorg Med Chem Lett; 2007 Mar; 17(6):1626-8. PubMed ID: 17254785 [TBL] [Abstract][Full Text] [Related]
12. Molecular design of anti-MRSA agents based on the anacardic acid scaffold. Green IR; Tocoli FE; Lee SH; Nihei K; Kubo I Bioorg Med Chem; 2007 Sep; 15(18):6236-41. PubMed ID: 17601740 [TBL] [Abstract][Full Text] [Related]
13. New broad-spectrum parenteral cephalosporins exhibiting potent activity against both methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa. Part 3: 7beta-[2-(5-Amino-1,2,4-thiadiazol-3-yl)-2-ethoxyiminoacetamido] cephalosporins bearing 4-[3-(aminoalkyl)-ureido]-1-pyridinium at C-3'. Yoshizawa H; Kubota T; Itani H; Minami K; Miwa H; Nishitani Y Bioorg Med Chem; 2004 Aug; 12(15):4221-31. PubMed ID: 15246098 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and potent antimicrobial activity of some novel 4-(5, 6-dichloro-1H-benzimidazol-2-yl)-N-substituted benzamides. Ozden S; Karataş H; Yildiz S; Göker H Arch Pharm (Weinheim); 2004 Oct; 337(10):556-62. PubMed ID: 15476288 [TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo activities of echinomycin against clinical isolates of Staphylococcus aureus. Park YS; Shin WS; Kim SK J Antimicrob Chemother; 2008 Jan; 61(1):163-8. PubMed ID: 17967852 [TBL] [Abstract][Full Text] [Related]
16. Reversing methicillin resistance in MRSA using a bacterial transforming agent. Carey BE; Dancer SJ J Antimicrob Chemother; 2006 Aug; 58(2):455-7. PubMed ID: 16787954 [TBL] [Abstract][Full Text] [Related]
17. Therapies and vaccines for emerging bacterial infections: learning from methicillin-resistant Staphylococcus aureus. John CC; Schreiber JR Pediatr Clin North Am; 2006 Aug; 53(4):699-713. PubMed ID: 16873000 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of oral hygiene products against MRSA and MSSA isolates. Smith AJ; Morrison D; Robertson D; Tang MK; Al-Doori Z J Antimicrob Chemother; 2003 Oct; 52(4):738-9. PubMed ID: 12917232 [No Abstract] [Full Text] [Related]
19. Synthesis, potent anti-staphylococcal activity and QSARs of some novel 2-anilinobenzazoles. Ozden S; Atabey D; Yildiz S; Göker H Eur J Med Chem; 2008 Jul; 43(7):1390-402. PubMed ID: 18022733 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and antimicrobial activity of some novel 2-[4-(substituted piperazin-/piperidin-1-ylcarbonyl)phenyl]-1H-benzimidazole derivatives. Kus C; Sözüdönmez F; Altanlar N Arch Pharm (Weinheim); 2009 Jan; 342(1):54-60. PubMed ID: 19051196 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]